Key result
Antibodies against the R-13 peptide were present in cardiac chagasic patients and congenitally infected newborns, but totally lacking in patients with the digestive form of Chagas' disease.
Why the study?
Are anti-R-13 antibodies associated with specific clinical manifestations of Trypanosoma cruzi infection?
Observational
Are anti-R-13 antibodies associated with specific clinical manifestations of Trypanosoma cruzi infection?
Anti-R-13 antibodies may serve as a specific biomarker for cardiac involvement and congenital infection in Chagas disease, distinguishing it from the digestive form.
May differentiate cardiac/congenital from digestive Chagas serologically; leaves open prognostic or therapeutic utility pending prospective studies.
Infection with Trypanosoma cruzi develops in three phases: acute, indeterminate or asymptomatic, and chronic phase (with cardiac or digestive manifestations). Moreover, transmission may occur from infected mothers to newborn, the so-called congenital form. In the present study, humoral responses against T. cruzi total extract and against the 13 amino acid peptide named R-13 derived from the parasite ribosomal P protein, previously described as a possible marker of chronic Chagas heart disease, were determined in chagasic patients and in blood bank donors from endemic areas. While in sera from acute phase, only IgM anti-T.cruzi response was observed, both IgM and IgG anti-T. cruzi antibodies were detected in sera from congenitally infected newborns. The percentage of positive response in sera from blood bank donors was relatively high in endemic regions. Antibodies against the R-13 peptide were present in a large proportion of cardiac chagasic patients but were totally lacking in patients with digestive form of Chagas' disease. Furthermore, anti-R-13 positive responses were detected in congenitally infected newborns.
No takes yet. Share an insight, caveat, or question.
Aznar et al. (1995) conducted an observational in Trypanosoma cruzi infection. Trypanosoma cruzi infection was evaluated on Humoral responses against T. cruzi total extract and R-13 peptide. Antibodies against the R-13 peptide were present in cardiac chagasic patients and congenitally infected newborns, but totally lacking in patients with the digestive form of Chagas' disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: